News and Announcements
Wholesale Investor Worldwide Tour Recap
- Published November 13, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19 days, 7 Cities, 6 Countries, 7 Showcase Events, 2 WI Private Cocktail Functions & 800 Attendees!
Written by Steve Torso, Wholesale Investor, Managing Director
The last 3 weeks have been the most ambitious mission we have ever embarked on.
Are we insane? Maybe! However, this is what drives us! Every day for us is about creating an opportunity for tomorrow. Our mission is to provide the platform for Emerging Companies to create trade and investment opportunities in new markets. It is a simple case of “you never know unless you try”.
In attendance we had Ultra High Net Worth Investors, Sovereign Funds, Individual and Multi-Family Offices, Fund Managers, Venture Capital and Private Equity firms, and the list goes on. It still fascinates me, that we have this level of money profile attending our events across so many countries.
Within the Wholesale Investor subscriber base, is a unique ecosystem. It is one that is constantly evolving, changing and growing.
What is beautiful about it, is that one conversation, one introduction or one registration of interest can change the entire destiny of a company and the people behind. The challenge is, you never know when, where or with whom that interaction will be.
- The companies which joined us for the journey
- The Australian High Commissioner to Singapore, Bruce Gosper and the Singapore Austrade team
- The Investors who engaged with our clients
- Our Shareholders. Thank you to the Investec and BMY Group teams for supporting our mission
- The Wholesale Investor team. There is a significant addition of pressure when you deliver events across multiple countries
- Shareinvestor, The Investor and KOTRA.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
